DelveInsight’s “Cytomegalovirus (CMV) Infection - Epidemiology Insights-2023- United States” Reports provides an overview of the disease and the historical and forecasted epidemiological data of the Cytomegalovirus (CMV) Infection for the United States for 2013-2023.
The report considers the transplant patients, HIV patients and Infants under high risk for CMV infections and epidemiology forecast for these high risk categories have also been taken into consideration. Out of all these high risk categories, CMV is more prevalent among the Transplant patients than HIV patients and Infants. As per DelveInsight’s estimation, the total number of Diagnosed CMV Infection cases in United States is expected to increase at a CAGR of 0.041% to 77,726 cases in 2023.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Identifying patient populations in the United States Cytomegalovirus (CMV) Infection market
• The Report covers the detailed historical and forecasted epidemiological data covering United States from 2013-2023.
'
Cytomegalovirus Infections
Disease Overview
Symptoms of cytomegalovirus (CMV) Infection
Etiology
Risk Factors
Pathogenesis of human cytomegalovirus
Pathophysiology of cytomegalovirus infection
Diagnosis
Epidemiology and Patient Population
United States
Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)
Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2016-2023)
CMV Patients among Transplants: Historical Data (2013-2015)
CMV Patients among Transplants: Forecasted Data (2016-2023)
Infants Patients at High Risk of CMV: Historical Data (2013-2015)
Infants Patients at High Risk of CMV: Forecasted Data (2016-2023)
HIV Patients at High Risk of CMV: Historical Data (2013-2015)
HIV Patients at High Risk of CMV: Forecasted Data (2016-2023)
Unmet Medical Needs
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight
Table 1:Total CMV Prevalent, Diagnosed and Treatable Cases: Historical Data (2013-2015)
Table 2:Total CMV Prevalent, Diagnosed and Treatable Cases: Forecasted Data (2017-2023)
Table 3:CMV Patients among Transplants: Historical Data (2013-2015)
Table 4: CMV Patients among Transplants: Forecasted Data (2017-2023)
Table 5: Infants Patients at High Risk of CMV: Historical Data (2013-2015)
Table 6: Infants Patients at High Risk of CMV: Forecasted Data (2017-2023)
Table 7: HIV Patients at High Risk of CMV: Historical Data (2013-2015)
Table 8: HIV Patients at High Risk of CMV: Forecasted Data (2017-2023)
